Haemonetics to Present at 43rd Annual J.P. Morgan Healthcare Conference
Haemonetics (NYSE: HAE) has announced its participation in the 43rd Annual J.P.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Haemonetics (NYSE: HAE) has announced its participation in the 43rd Annual J.P. Morgan Healthcare Conference in San Francisco. Chris Simon, President and CEO, is scheduled to present on Tuesday, January 14, 2025, at 5:15 pm Pacific Time.
The presentation will be accessible to the public through a live audio webcast via the conference platform and through Haemonetics' Investor Relations website under the Events & Presentations section. A replay of the presentation will remain available for 30 days following the event, accessible through both platforms approximately one hour after the live presentation concludes.
Details
News Market Reaction – HAE
The recorded move for HAE in the trading session of this news was -1.55%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
The public may access Mr. Simon's presentation live via audio webcast at:
The live webcast can also be accessed under the Events & Presentations section of Haemonetics' Investor Relations website. The replay of the presentation will be available for 30 days using the link provided above and on Haemonetics' Investor Relations website beginning approximately one hour after completion of the live event.
ABOUT HAEMONETICS
Haemonetics (NYSE: HAE) is a global healthcare company dedicated to providing a suite of innovative medical products and solutions for customers, to help them improve patient care and reduce the cost of healthcare. Our technology addresses important medical markets: blood and plasma component collection, the surgical suite and hospital transfusion services. To learn more about Haemonetics, visit www.haemonetics.com.
Investor Contacts: | |
Olga Guyette, Vice President-Investor Relations & Treasury | David Trenk, Manager-Investor Relations |
(781) 356-9763 | (203) 733-4987 |
Media Contact: | |
Josh Gitelson, Sr. Director-Global Communications | |
(781) 356-9776 | |
View original content to download multimedia:https://www.prnewswire.com/news-releases/haemonetics-to-present-at-43rd-annual-jp-morgan-healthcare-conference-302342258.html
SOURCE Haemonetics Corporation
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.